LL
Eli Lilly
LLY · NYSE
$1,148.74 -0.94% (-$10.86)
1M -3.16%
Market Cap $1.09T
P/E Ratio 40.88x
Div. Yield 0.56%
ROE 92.58%
Bulios Fair Price
$589.23
48.7% downside
Trenutna cena
$1,149
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LLY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
11 /100
Expensive P/E 40.88x
EV/EBITDA 32.32x
P/S 13.71x
Growth
100 /100
Growing EPS growth 51.73%
Rev. growth 31.69%
FCF growth 24.94%
Profitability
100 /100
Strong Gross margin 84.01%
Net margin 33.53%
Op. margin 43.92%
Quality
92 /100
Excellent ROIC 27.38%
ROE 92.58%
ROA 18.77%
Debt
67 /100
Low Debt/Equity 1.62x
Current ratio 1.35x
Int. coverage 34.79x
Stability
64 /100
Moderate Beta 0.50x
Rev. volatility 12.57%
EPS volatility 63.96%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LLY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
David A. Ricks
Employees
50,000
Headquarters
Indianapolis
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report